Dahar kacang tiasa ngabantosan kanker usus besar

Bagikeun Post Ieu

Numutkeun kana ulikan CALGB 8903 diterbitkeun dina Journal of Clinical Oncology, penderita kanker usus tahap III anu ngahakan sahenteuna 2 porsi kacang per minggu ngagaduhan survival bébas panyakit (DFS) sareng kasalametan umum (OS) anu langkung luhur. Asosiasi antara total asupan kacang jeung hasil ningkat konsisten diantara séjén dipikawanoh atawa disangka faktor résiko keur kambuh kanker sarta maot.

Dr. Charles S. Fuchs of the Yale Cancer Center and colleagues wrote: “This prospective study of patients with stage III kanker titik shows that a diet with increased nut consumption is associated with a significant reduction in cancer recurrence and mortality. Although we observed The results of sex studies cannot determine causality, but the results further support diet and lifestyle as modifiable risk factors for patients with colon cancer. “

This study conducted a 6.5-year follow-up survey of 826 colon cancer patients treated with surgery and chemotherapy. The results showed that people who consumed at least two ounces of nuts per week had a 42% increase in disease-free survival and an increase in overall survival. 57%.

Panaliti nyarios: "Analisis langkung seueur ngeunaan kohort nunjukkeun yén kasalametan jalma anu teu aya panyakit anu ngonsumsi kacang ningkat sacara signifikan. Kacangan kaasup almond, walnuts, hazelnuts, cashews, walnuts, jsb Sabalikna, kacang sabenerna jenis kadaharan buncis. Hasil ieu konsisten sareng panilitian observasi anu sanés nunjukkeun yén sauntuyan paripolah kaséhatan, kalebet ningkatkeun kagiatan fisik, ngajaga beurat séhat, sareng asupan gula sareng inuman amis anu langkung handap tiasa ningkatkeun tingkat kasalametan kanker usus besar. “

Papanggihan nekenkeun pentingna faktor diet sareng gaya hirup dina kasalametan kanker usus besar. In addition, the researchers emphasized that the study emphasized the connection between biological mechanisms of not only colon cancer but also certain chronic diseases, such as type 2 diabetes, which worsens the disease.

Ngalanggan Pikeun Newsletter kami

Meunang apdet sarta pernah sono blog ti Cancerfax

Langkung Kanggo Ngajalajah

Terapi Sél CAR T Berbasis Manusa: Terobosan sareng Tantangan
Terapi T-Cell mobil

Terapi Sél CAR T Berbasis Manusa: Terobosan sareng Tantangan

Terapi CAR T-sél basis manusa revolutionizes pengobatan kanker ku genetik modifying sél imun hiji sabar urang sorangan pikeun sasaran sarta ngancurkeun sél kanker. Ku ngamangpaatkeun kakuatan sistem imun awak, terapi ieu nawiskeun pangobatan anu kuat sareng pribadi sareng poténsial pikeun remisi anu berkepanjangan dina sababaraha jinis kanker.

Ngartos Sindrom Pelepasan Sitokin: Nyababkeun, Gejala, sareng Pangobatan
Terapi T-Cell mobil

Ngartos Sindrom Pelepasan Sitokin: Nyababkeun, Gejala, sareng Pangobatan

Cytokine Release Syndrome (CRS) mangrupikeun réaksi sistem imun anu sering dipicu ku sababaraha pangobatan sapertos immunotherapy atanapi terapi sél CAR-T. Éta ngalibatkeun sékrési sitokin anu kaleuleuwihan, nyababkeun gejala mimitian ti muriang sareng kacapean dugi ka komplikasi anu ngancam kahirupan sapertos karusakan organ. Manajemén butuh strategi ngawaskeun sareng intervensi anu ati-ati.

Peryogi bantosan? Tim kami siap ngabantosan anjeun.

Kami ngarepkeun pamulihan gancang tina anu anjeun sayogi sareng anu caket.

Mimitian obrolan
Kami Online! Ngobrol Jeung Kami!
Scan kode na
Halo,

Wilujeng sumping di CancerFax!

CancerFax mangrupikeun platform pioneering anu didedikasikeun pikeun ngahubungkeun individu anu nyanghareupan kanker tahap lanjut kalayan terapi sél anu inovatif sapertos terapi CAR T-Cell, terapi TIL, sareng uji klinis di sakuliah dunya.

Hayu urang nyaho naon bisa urang pigawé pikeun anjeun.

1) Pangobatan kanker di luar negeri?
2) Terapi T-Sél mobil
3) Vaksin kanker
4) Konsultasi video online
5) Terapi proton